| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RGK11302B |
Anti-Ganglioside GD3 Antibody (R24) |
1mg |
$1,880.00
|
 |
BUY
|
| RGK11302A |
Anti-Ganglioside GD3 Antibody (R24) |
100µg |
$420.00
|
|
BUY
|
| RHC82420A |
Anti-Human MAPT/Tau/PHF-tau (MC1) mAb |
100 µg |
$475.00
|
|
BUY
|
| RHC82420B |
Anti-Human MAPT/Tau/PHF-tau (MC1) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RHG93502B |
Anti-Human SLC10A1 Nanobody (SAA1065) mAb |
1.0 mg |
$2,155.00
|
|
BUY
|
| RHG93502A |
Anti-Human SLC10A1 Nanobody (SAA1065) mAb |
100 µg |
$475.00
|
|
BUY
|
| RHG93503A |
Anti-Human SLC10A1 Nanobody (SAA1095) mAb |
100 µg |
$475.00
|
|
BUY
|
| RHG93503B |
Anti-Human SLC10A1 Nanobody (SAA1095) mAb |
1.0 mg |
$2,155.00
|
|
BUY
|
| RHC59302A |
Anti-K48-linked Polyubiquitin (SAA0329) mAb |
100 µg |
$475.00
|
|
BUY
|
| RHC59302B |
Anti-K48-linked Polyubiquitin (SAA0329) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RRJ12901B |
Anti-Rat ARC Nanobody (SAA1466) mAb |
1.0 mg |
$2,155.00
|
|
BUY
|
| RRJ12901A |
Anti-Rat ARC Nanobody (SAA1466) mAb |
100 µg |
$475.00
|
|
BUY
|
| RXX11501B |
Human Anti-Bordetella pertussis fhaB/FHA (T5) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RXX11501A |
Human Anti-Bordetella pertussis fhaB/FHA (T5) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC524A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC530A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC530B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC531A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC531B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC517A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC517B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC518A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC518B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC526B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC526A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC510B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC510A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC525B |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC525A |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC511B |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC511A |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| FHB65410B |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
1.0 mg |
$1,562.00
|
|
BUY
|
| FHB65410A |
Humanized Anti-Human SLC34A2 / NaPi2b (SAA0766) mAb |
100 ug |
$330.00
|
|
BUY
|
| FHK06810B |
Humanized Anti-Human SLITRK6 (SAA0827) mAb |
100 ug |
$475.00
|
|
BUY
|
| FHK06810C |
Humanized Anti-Human SLITRK6 (SAA0827) mAb |
1.0 mg |
$1,720.00
|
|
BUY
|
| FHK06810A |
Humanized Anti-Human SLITRK6 (SAA0827) mAb |
50 ug |
$310.00
|
|
BUY
|
| FMF90710C |
Mouse Anti-Human / Mouse ROR1 (R11) mAb |
1.0 mg |
$1,720.00
|
|
BUY
|
| FMF90710A |
Mouse Anti-Human / Mouse ROR1 (R11) mAb |
50 ug |
$330.00
|
|
BUY
|
| FMF90710B |
Mouse Anti-Human / Mouse ROR1 (R11) mAb |
100 ug |
$475.00
|
|
BUY
|
| RHF90706A |
Mouse Anti-Human ROR1 / NTRKR1 (4C10) mAb |
100 ug |
$380.00
|
|
BUY
|
| RHF90706B |
Mouse Anti-Human ROR1 / NTRKR1 (4C10) mAb |
1.0 mg |
$1,700.00
|
|
BUY
|
| CPC519A |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC519B |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| DHB94401B |
Research Grade Certolizumab |
1.0 mg |
$1,970.00
|
|
BUY
|
| DHB94401A |
Research Grade Certolizumab |
100 ug |
$540.00
|
|
BUY
|
| DHJ45501B |
Research Grade Vixarelimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DHJ45501A |
Research Grade Vixarelimab |
100 ug |
$420.00
|
|
BUY
|
